ABCL
Price
$11.39
Change
+$0.42 (+3.83%)
Updated
Aug 14, 04:59 PM (EDT)
Capitalization
3.37B
88 days until earnings call
Intraday BUY SELL Signals
SLN
Price
$13.75
Change
-$0.22 (-1.57%)
Updated
Aug 14, 04:59 PM (EDT)
Capitalization
848.81M
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs SLN

ABCL vs SLN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. SLN commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (ABCL: $10.97 vs. SLN: $13.97)
Brand notoriety: ABCL and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 177% vs. SLN: 260%
Market capitalization -- ABCL: $3.37B vs. SLN: $848.81M
ABCL [@Biotechnology] is valued at $3.37B. SLN’s [@Biotechnology] market capitalization is $848.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $130.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ABCL and SLN are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +67.99% price change this week, while SLN (@Biotechnology) price change was +19.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.59%. For the same industry, the average monthly price growth was -1.35%, and the average quarterly price growth was +2889.08%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

SLN is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (+0.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($3.37B) has a higher market cap than SLN($849M). ABCL YTD gains are higher at: 220.760 vs. SLN (129.770). SLN has higher annual earnings (EBITDA): -76.56M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. SLN (70.1M). SLN has less debt than ABCL: SLN (136K) vs ABCL (140M). ABCL has higher revenues than SLN: ABCL (79.2M) vs SLN (839K).
ABCLSLNABCL / SLN
Capitalization3.37B849M397%
EBITDA-167.02M-76.56M218%
Gain YTD220.760129.770170%
P/E RatioN/AN/A-
Revenue79.2M839K9,440%
Total Cash505M70.1M720%
Total Debt140M136K102,941%
FUNDAMENTALS RATINGS
SLN: Fundamental Ratings
SLN
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLSLN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 8 days ago
89%
Declines
ODDS (%)
Bearish Trend 19 days ago
81%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSIFX28.460.09
+0.32%
Saturna International
FCISX2.64N/A
N/A
Franklin Income C
HFCIX41.36N/A
N/A
Hennessy Focus Institutional
BOSVX23.19N/A
N/A
Bridgeway Omni Small-Cap Value N
TRHBX31.83N/A
N/A
Nuveen Small Cap Blend Idx I

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+2.87%
CLLS - SLN
43%
Loosely correlated
+8.16%
RCUS - SLN
38%
Loosely correlated
-0.35%
ABCL - SLN
37%
Loosely correlated
+5.94%
BEAM - SLN
36%
Loosely correlated
-0.75%
VIR - SLN
34%
Loosely correlated
+0.45%
More